CAMBRIDGE, Mass.--(BUSINESS WIRE)--Archemix Corp, a biotechnology company focused on discovering, developing and commercializing aptamer therapeutics, today announced that Dr. Errol De Souza, Archemix’s President and Chief Executive Officer, will present at the 28th Annual Canaccord Adams Global Growth Conference in Boston on Wednesday, August 13th at 11:30 a.m. In his presentation Dr. De Souza will provide an update on Archemix’s product portfolio, including the company’s ARC1779 aptamer, and strategic and business initiatives and goals for 2008.
